MedTrace Logo

Knee Osteoarthritis With Stromal Vascular Fraction Cells

NCT07259993 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-12-02

No results posted yet for this study

Summary

This is an interventional study to treat knees osteoarthritis (KOA) with adipose-derived stromal vascular fraction cell components in sixteen subjects with either unilateral or bilateral symptomatic Kellgren Lawence Grade 3 KOA by intra-articular injection of knees. Later, subjects were followed for safety out and potential benefits.

Conditions

Interventions

BIOLOGICAL

autologous adipose tissue-derived stromal vascular fraction cells

SVF cells via intra-articular injection into knees

Sponsors & Collaborators

  • Wake Forest University

    collaborator OTHER

  • Ministry of Health Nicaragua

    collaborator UNKNOWN

  • Hospital Vivian Pellas, Nicaragua

    collaborator UNKNOWN

  • University of California, San Francisco

    collaborator OTHER

  • Michael H Carstens

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-27
Primary Completion
2025-07-26
Completion
2025-10-30

Countries

  • Nicaragua

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07259993 on ClinicalTrials.gov